Data / Research funding / New Hampshire / Vaxsyna, Inc.
Vaxsyna, Inc.: 1 NIH award ($437.2K), fiscal years 2021 to 2026
Vaxsyna, Inc. in Franklin, NH is funded under 1 NIH award ($437.2K) in the NIH and NSF award files, read 2026-11-03. NIH fiscal years 2021 to 2025; NSF fiscal years 2022 to 2026.
SpecStream is the live web data engine for teams and agents. It reads the NIH and NSF award files each time the agencies update them, and this page is that reading, joined to the open federal funding opportunities on Grants.gov. Ask for the awards you track by topic, organization or state and new awards arrive in your sheet, CRM, Slack or agent as the agencies publish them.
- NIH institution profile
- 10066334
- State
- New Hampshire
- Note
- NIH gives no UEI for this institution, so NSF awards are not matched.
Awards
1 awards in the window.
| Award | Agency | Institute or division | Fiscal year | Amount in window | Start | End | Principal investigator | Source |
|---|---|---|---|---|---|---|---|---|
| Low cost, Broad Spectrum Cancer Vaccine Targeting Human Papillomavirus | NIH | National Cancer Institute | 2022 | $437,203 | July 1, 2022 | March 31, 2025 | PARDHE, MARY | reporter.nih.gov |
Funding by fiscal year
| Fiscal year | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|
| 2022 | 1 | $437,203 | 0 | $0 |
Open federal funding opportunities
From Grants.gov: notices that funded awards in this table, and open notices on the same agency and assistance listing.
| Open opportunity | Number | Agency | Listing | Closes | Award ceiling | Why it matches |
|---|---|---|---|---|---|---|
| Change of Recipient Organization (Type 7 Parent Clinical Trial Optional) | PA-24-254 | NIH | 93.353 | July 12, 2027 | Not listed | Same assistance listing 93.353 as 1 award here |
| Successor-in-Interest (Type 6 Parent Clinical Trial Optional) | PA-24-253 | NIH | 93.353 | July 17, 2027 | Not listed | Same assistance listing 93.353 as 1 award here |
Topics of its NIH awards
- Biotechnology
- Cancer
- Cervical Cancer
- Dental/Oral and Craniofacial Disease
- Digestive Diseases
- HPV and/or Cervical Cancer Vaccines
- Immunization
- Immunotherapy
- Infectious Diseases
- Orphan Drug
- Prevention
- Rare Diseases
Updated November 3, 2026. Read from NIH RePORTER ExPORTER and NSF Award Search. Published by NIH and NSF as U.S. government data. NIH awards are fiscal years 2021 to 2025 (NIH files published to 2026-07-09); NSF awards are fiscal years 2022 to 2026 (NSF files published to 2026-11-02). NIH amounts are the total cost of each fiscal year in the window; NSF amounts are the funds obligated in the window. Organizations are matched on the UEI. Open opportunities come from Grants.gov and match on agency and assistance listing number, and on the notice number NIH prints on an award. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.